Navigation Links
51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care

NEW ORLEANS, Dec. 1 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH), the world's largest professional association of blood specialists, expects more than 20,000 attendees at the 51st ASH Annual Meeting from December 5-8, 2009, at the Ernest N. Morial Convention Center in New Orleans, LA. The meeting will showcase the latest research and treatments for blood disorders.

"It is my pleasure to host ASH's 51st annual meeting, where we will celebrate the start of the 'next 50 years' of ASH with an update on continuing advances in hematology," said Nancy Berliner, M.D., 2009 ASH President, and Chief of Hematology at Brigham and Women's Hospital in Boston and a Professor of Medicine at Harvard Medical School. "The meeting will feature emerging research trends in the diagnosis, treatment, and understanding of many blood disorders and cancers, and will also highlight other issues affecting physicians and their patients, such as the skyrocketing cost of health care and changes to U.S. health-care policies."

Highlights of the meeting include special symposia, education programs, special-interest seminars, and scientific sessions.

This year's 200th anniversary of Charles Darwin's birth as well as the 150th anniversary of the publication of his book, On the Origin of Species, will be reflected upon in the Ham-Wasserman Lecture. The speaker, Melvyn F. Greaves, Ph.D., will focus on the development of leukemia from a Darwinian perspective and the relevance of evolutionary biology to medicine. The lecture will take place on Saturday, December 5, from 12:30 - 1:30 p.m. Another hot topic - how increased understanding of cancer stem cells will result in improved prognosis and therapies - will be explored in detail by John E. Dick, Ph.D., during the E. Donnall Thomas Lecture on Monday, December 7, from 9:00 - 10:00 a.m. On Monday, December 7, ASH's new Ernest Beutler Lecture and Prize will be awarded to Thomas Maniatis, Ph.D., of Harvard University, and Yuet Wai Kan, M.D., from the University of California, San Francisco. The lecture will be presented from 1:30 - 2:30 p.m. and will focus on the impact of molecular genetic studies of globin genes on the diagnosis and treatment of thalassaemia.

The Special Symposium on the Basic Science of Hemostasis and Thrombosis will focus on this year's most important basic science contributions to each of the three major areas of the field: thrombosis, blood coagulation and fibrinolysis, and platelet biology. The invited presentations for the symposium will take place on Tuesday, December 8, from 7:30 - 9:00 a.m., and simultaneous oral sessions will take place from 12:00 - 1:30 p.m. In addition, Melanie Bloom, national patient spokesperson for the Coalition to Prevent Deep-Vein Thrombosis, will receive ASH's Outstanding Service Award in recognition of her dedication to increasing public awareness of DVT on Sunday, December 6, from 1:30 - 2:00 p.m.

This year's Practice Forum, "New Health-Care Policies and the Practice of Hematology," will address how new health-care policies will affect medical practice, including a discussion of changes in reimbursement that are expected by Medicare in 2010. This event will take place Saturday, December 5, from 6:00 - 7:30 p.m. Additionally, the ASH/EHA Policy Forum, co-sponsored with the European Hematology Association, will feature noted health economist Paul B. Ginsburg, Ph.D., President of the Center for Studying Health System Change, who will discuss the cost of health care and balancing a patient's right to care with the high cost of some drugs and procedures. The forum will take place on Sunday, December 6, from 12:30 - 1:30 p.m.

On the last day of the meeting, the Presidential Symposium will focus on novel genomic approaches for the diagnosis and treatment of hematologic malignancies. Louis M. Staudt, M.D., Ph.D., from the National Cancer Institute, and this year's Dameshek Prize winner, will be a featured speaker, along with Timothy Ley, M.D., from Washington University in St. Louis, and Todd Golub, M.D., from the Broad Institute of Harvard and MIT. The symposium will take place on Tuesday, December 8, from 9:45 - 11:15 a.m.

For the complete annual meeting program and abstracts, visit Up-to-date annual meeting information can also be obtained by following ASH on Twitter at ASH_hematology.

American Society of Hematology

The American Society of Hematology ( is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. ASH provides Blood: The Vital Connection (, a credible online resource addressing bleeding and clotting disorders, anemia, and cancer. The official journal of ASH is Blood (, the most cited peer-reviewed publication in the field, which is available weekly in print and online.

Ernest N. Morial Convention Center (Dec. 4-8): 504-670-7005

SOURCE American Society of Hematology

SOURCE American Society of Hematology
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. More than 1,000 patients in US admitted annually for aviation-related injuries
2. Tyco International Sets Date for 2010 Annual General Meeting of Shareholders
3. BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of 106 & PARK and on the Ground Initiatives Through BETs Award Winning Public Affairs Campaign Rap-It-Up
4. 18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact
5. Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer
6. The Advisory Board Company to Present at 21st Annual Piper Jaffray Health Care Conference
7. Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer
8. Providence Service Corporations LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida
9. Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research
10. Regeneron Announces Presentation at the 21st Annual Piper Jaffray Healthcare Conference
11. NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator ... the latest addition to the devices for sale in the United States. Clarity ... and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is easy to ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... has selected 10 semi-finalists to head to Las Vegas for CES 2016, the world’s ... including CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica ...
(Date:12/1/2015)... ... 2015 , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, has ... The order will be from the China Disabled Persons’ Federation, a central government association, ... solution for children and adults suffering from severe and profound hearing loss . ...
(Date:12/1/2015)... ... December 01, 2015 , ... Tympani Inc., announced ... (ATP) status from Cisco. This designation recognizes Tympani as having fulfilled the training ... solutions targeted to the high-end enterprise contact center marketplace. , Ed Kapelinski, President ...
(Date:11/30/2015)... , ... November 30, 2015 , ... Trevor and Taylor ... as they play for the chance to represent the United States. This hybrid ... to be a part of their journey in addition to offering corporate sponsors with ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... UPPSALA, Sverige, December 1, 2015 ... Breast Cancer Study Group (IBCSG, Bern ... att ingå i en klinisk studie av palbociclib, ... --> Studien, med namn PYTHIA, ... med anti-hormonella läkemedel i kombination med palbociclib, som ...
(Date:11/30/2015)... MAPLE GROVE, Minn. and BASEL, ... Upsher-Smith Laboratories, Inc. (Upsher-Smith), through its wholly-owned ... for the further development of a novel, oral small ... cell-adhesion molecule that may be effective in the treatment ... Phase II clinical development. --> ...
(Date:11/30/2015)... Dec. 1, 2015 Express Scripts (NASDAQ: ESRX ... IMMY ) to drive access to a low-cost alternative ... of toxoplasmosis that has been recently priced out of reach ... immune systems. --> --> ... leucovorin (a form of folic acid) for $1 per capsule for ...
Breaking Medicine Technology: